Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Teva
Queensland Health
QuintilesIMS
Baxter
Federal Trade Commission
McKinsey
US Department of Justice
Mallinckrodt

Generated: July 18, 2018

DrugPatentWatch Database Preview

Ethambutol hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for ethambutol hydrochloride and what is the scope of ethambutol hydrochloride freedom to operate?

Ethambutol hydrochloride
is the generic ingredient in two branded drugs marketed by Akorn, Barr, Lupin, and Sti Pharma Llc, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for ethambutol hydrochloride. Thirteen suppliers are listed for this compound.
Pharmacology for ethambutol hydrochloride
Medical Subject Heading (MeSH) Categories for ethambutol hydrochloride

US Patents and Regulatory Information for ethambutol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr ETHAMBUTOL HYDROCHLORIDE ethambutol hydrochloride TABLET;ORAL 076057-001 Nov 26, 2001 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Akorn ETHAMBUTOL HYDROCHLORIDE ethambutol hydrochloride TABLET;ORAL 075095-002 Nov 30, 1999 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lupin ETHAMBUTOL HYDROCHLORIDE ethambutol hydrochloride TABLET;ORAL 078939-001 Jun 17, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sti Pharma Llc MYAMBUTOL ethambutol hydrochloride TABLET;ORAL 016320-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Medtronic
Mallinckrodt
McKinsey
Queensland Health
Accenture
Daiichi Sankyo
Fish and Richardson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.